Trials / Completed
CompletedNCT01047475
A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer (FDA IND 103675)
A Phase II Trial of MB-6 Plus FOLFOX4 for Metastatic Colorectal Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Microbio Co Ltd · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, parallel group, placebo-controlled study evaluate the preliminary efficacy and safety of MB-6 (320 mg/capsule, 6 capsules tid) versus placebo in addition to standard chemotherapy in the treatment of patients with metastatic colorectal cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MB-6 | 6# TID with meal |
| DRUG | Placebo | 6# TID with meal |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-04-01
- Completion
- 2011-12-01
- First posted
- 2010-01-13
- Last updated
- 2015-05-13
- Results posted
- 2015-05-13
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01047475. Inclusion in this directory is not an endorsement.